New Key Statistics Module, Z-Score and F-Score
OTCPK:MEDIF Key Ratios
Market Cap $ M | 23.58 |
Enterprise Value $ M | 12.80 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.65 |
Price/Sales | 0.90 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 27.00 |
EPS (TTM) $ | -0.03 |
Beneish M-Score | 17.04 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.31 |
EV-to-EBITDA | -1.66 |
PEG | -- |
Shares Outstanding M | 404.82 |
Net Margin (%) | -36.78 |
Operating Margin % | -49.04 |
Pre-tax Margin (%) | -37.53 |
Quick Ratio | 2.20 |
Current Ratio | 3.07 |
ROA % (ttm) | -20.69 |
ROE % (ttm) | -25.13 |
ROIC % (ttm) | -41.46 |
Dividend Yield % | -- |
Altman Z-Score | -2.08 |
MEDIF Number of Guru Trades
MEDIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MEDIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MEDIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
MediPharm Labs Corp Insider Transactions
No Available Data
News about OTCPK:MEDIF
Total 0- 1